← Back
$ONC All transactions

BeOne Medicines Ltd.

▼ SELL

$ Value

$354K

Shares

1,363

Price

$260

Filed

Jun 25

Insider

Name

Wu Xiaobin

Title

President and COO

CIK

0001739452

Roles

Officer

Transaction Details

Transaction Date

2025-06-23

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each American Depositary Share represents 13 Ordinary Shares. | The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

Filing Info

Accession No.

0001651308-25-000117

Form Type

4

Issuer CIK

0001651308

Wu Xiaobin's History

Date Ticker Type Value
2026-03-06 ONC A $0
2026-03-06 ONC A $0
2025-11-17 ONC $1.2M
2025-11-17 ONC $315K
2025-11-17 ONC $4K
2025-11-13 ONC $1.6M
2025-11-13 ONC $674K
2025-11-12 ONC $175K
2025-11-12 ONC $1.1M
2025-11-12 ONC $278K

Other Insiders at ONC (90d)

Insider Bought Sold Last
OYLER JOHN
Chief Executive Officer
2026-03-06
Wu Xiaobin
President and COO
2026-03-06
Wang Lai
President, Global Head of R&D
2026-03-06
Lee Chan Henry
SVP, General Counsel
$786K 2026-04-08
Rosenberg Aaron
Chief Financial Officer
2026-03-06